ESR1 and breast cancer: PRSBC and PRSER+ were associated with larger odds ratio estimates than PRSER- in predicting breast cancer risk, consistent with the fact that most breast cancers in men are ER positive, including those harboring BRCA1 and BRCA2 pathogenic variants (26).